<DOC>
	<DOCNO>NCT00102882</DOCNO>
	<brief_summary>This study may last 36-38 week . Patients visit clinic 11 time . A blood sample take Visit 1 look subject ' gene . Breathing test do study . Study medicine procedure provide cost . Patients treat VENTOLIN ( 8 wks ) , ATROVENT ( 8 wks ) , ADVAIR SEREVENT ( 16 wks ) . ADVAIR SEREVENT FDA approve treatment asthma patient 4 year age old .</brief_summary>
	<brief_title>Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate</brief_title>
	<detailed_description>A Randomized , Parallel Group , Double-Blind , Comparative Trial Assessing Lung Function Other Measures Asthma Control Adults Adolescents , least 12 Years Age , Persistent Asthma , Who Have Either B16-Arg/Arg , B16-Gly/Gly B-16 Arg/Gly Genotype Treated With Fluticasone Propionate/Salmeterol DISKUSâ„¢ Combination Product 100/50mcg Salmeterol DISKUS 50 mcg BID</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Diagnosis persistent asthma 3 month . Use shortacting betaagonist medication like VENTOLIN . Exclusion criterion : Hospitalization asthma 6 month study . Other serious disease like congestive heart failure , uncontrolled hypertension , TB . Current use inhale oral corticosteroid .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>genotype</keyword>
	<keyword>Salmeterol</keyword>
	<keyword>ADVAIR</keyword>
</DOC>